Repligen | RGEN - PE Price to Earnings


Repligen reported 109.48 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Agilent 20.53 4.51 Mar/2026
Align Technology 22.78 3.05 Mar/2026
Bio Techne 38.75 81.27 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Bruker 36.79 44.56 Mar/2026
Charles River Laboratories 29.26 14.31 Mar/2026
Danaher 29.29 10.39 Mar/2026
Dentsply International 20.31 9.68 Mar/2026
General Electric Aerospace 34.26 4.95 Mar/2026
Henry Schein 16.89 1.54 Mar/2026
Illumina 32.45 2.07 Mar/2026
IQVIA Holdings 19.37 7.21 Mar/2026
Mettler Toledo International 27.34 5.07 Mar/2026
OraSure Technologies 24.42 12.6 Sep/2024
Pfizer 9.32 5.16 Mar/2026
Repligen 109.48 54.58 Mar/2026
Revvity 30.79 19.08 Mar/2026
Thermo Fisher Scientific 27.71 3.29 Mar/2026
Waters 29.75 5.54 Mar/2026
West Pharmaceutical Services 31.99 5.76 Mar/2026